GLUT1 has found to be overexpressed in various cancers, such as esophageal squamous cell carcinoma [8], gastric carcinoma [9] and colon cancer (CC) [10, 11], and is significantly associated with worse prognosis [11]. Here, SLC2A1 is linked to malignant colon neoplasm.